Veronika Kapustova

Ostrava, MO, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Anti-BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma.

Anti-BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma.

Journal: HemaSphere

Published: May 20, 2026

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Journal: Molecular diagnosis & therapy

Published: October 22, 2025

Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.

Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.

Journal: HemaSphere

Published: June 21, 2025

Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.

Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.

Journal: Blood cancer discovery

Published: May 15, 2025

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Journal: Blood

Published: April 14, 2025

Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.

Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.

Journal: Blood

Published: April 14, 2025

Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients.

Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients.

Journal: American journal of hematology

Published: November 04, 2024

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Journal: Leukemia

Published: December 12, 2023

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Journal: British journal of haematology

Published: August 06, 2023

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 31, 2022

Fine structure and transcription dynamics of bread wheat ribosomal DNA loci deciphered by a multi-omics approach.

Fine structure and transcription dynamics of bread wheat ribosomal DNA loci deciphered by a multi-omics approach.

Journal: The plant genome

Published: August 31, 2021

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.

Journal: Leukemia

Published: April 24, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026